Cargando…

Passive immunotherapy of extended peritonitis as abdominal sepsis prevention

Detalles Bibliográficos
Autores principales:	Butyrsky, Olexandr, Starosek, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953039/ http://dx.doi.org/10.1186/cc12906

Ejemplares similares

Efficacy of specific immunotherapy of abdominal sepsis
por: Butyrsky, Olexandr, et al.
Publicado: (2013)

Anti-endotoxin immunity in abdominal sepsis patients
por: Butyrsky, O, et al.
Publicado: (2011)

Immunoglobulin therapy of abdominal sepsis in emergency surgery
por: Butyrsky, O, et al.
Publicado: (2012)

Abdominal sepsis: efficacy of passive immunotherapy
por: Knut, Ruslan, et al.
Publicado: (2007)

Compartmentalization of the inflammatory response in abdominal sepsis
por: Grigoryev, E
Publicado: (2008)

Severe abdominal sepsis in the intensive care unit
por: Morar, R
Publicado: (2004)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Bioreactance-based passive leg raising test can predict fluid responsiveness in patients with sepsis
por: Hu, C, et al.
Publicado: (2015)

Clinical audit system in implementing Surviving Sepsis Campaign guidelines in patients with peritonitis
por: Valiveru, RC, et al.
Publicado: (2014)

Epidemiology of ventilator associated pneumonia (vap) in patients with abdominal sepsis
por: Hom Choudhuri, A, et al.
Publicado: (2015)

Different correlations between lymphocyte subsets from patients with intra-abdominal sepsis and pneumonia-derived sepsis
por: Skirecki, TS, et al.
Publicado: (2011)

Altered plasma proteome during an early phase of an experimental model of peritonitis-induced sepsis
por: Karvunidis, T, et al.
Publicado: (2009)

Prevention of sepsis by correcting apoptosis
por: Puhtinskaya, M, et al.
Publicado: (2013)

Prognostic scoring systems-validation and their utility in patients with abdominal sepsis in colon peritonitis
por: Teleanu, G, et al.
Publicado: (2014)

Serum C-reactive protein concentration in early abdominal and pulmonary sepsis
por: Orati, JA, et al.
Publicado: (2013)

Effects of nitroglycerin on intestinal microcirculatory blood flow in patients with abdominal sepsis
por: Roossien, F, et al.
Publicado: (2010)

Early abdominal and pulmonary neutrophil accumulation and activation in patients with secondary peritonitis: a compartmentalized response
por: van Till, O, et al.
Publicado: (2004)

Abdominal organs' microcirculation dysfunction sequence in severe sepsis by SDF microscopy and histology
por: Almeida-Filho, J, et al.
Publicado: (2012)

Role of the clarithromycin immune modulator activity on abdominal microhemodynamics and mortality in severe sepsis
por: Jesus, FRE, et al.
Publicado: (2012)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

Effects of sepsis on respiratory mechanics in a porcine model of intra-abdominal hypertension
por: Fyntanidou, B, et al.
Publicado: (2015)

Transthoracic echocardiography used in conjunction with passive leg raising for assessment of fluid responsiveness in severe sepsis or septic shock patients
por: Jaikriengkrai, K, et al.
Publicado: (2014)

Are extended and continuous infusions of time dependent antibiotics used in the management of sepsis in england today?
por: Dunning, JA, et al.
Publicado: (2015)

Neuroaxial catheters following abdominal surgery and their impact on the use of Drotrecogin alfa (activated) in sepsis
por: Steel, A, et al.
Publicado: (2004)

Pre-existing systemic inflammation attenuates bacterial clearance by the liver in porcine abdominal sepsis
por: Hanslin, K, et al.
Publicado: (2015)

Tissue and plasma putrescine levels in non-survivors of sepsis in a fluid-resuscitated rat model of faecal peritonitis
por: Andreis, DT, et al.
Publicado: (2015)

Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock
por: Reintam, A, et al.
Publicado: (2007)

Fibrinolysis in early recognition of sepsis in patients with severe trauma
por: Gerasimov, Lev, et al.
Publicado: (2007)

Extending the classification of healthcare-associated bloodstream infection to other main foci: respiratory, urinary and intra-abdominal
por: Cardoso, C, et al.
Publicado: (2011)

Forty percent of hospitalizations after severe sepsis are potentially preventable
por: Prescott, HC, et al.
Publicado: (2014)

N-terminal pro-BNP predicts mortality better than procalcitonin in abdominal severe sepsis and septic shock
por: Ruiz-Vera, N, et al.
Publicado: (2011)

A role for immunotherapy: preventing macrophage anergy in the tumour environment
por: Elia, Androulla, et al.
Publicado: (2013)

Technique of temporary abdominal closure in abdominal compartment syndrome for preventing environmental contamination: seal and continuous high-pressure aspiration
por: Moriwaki, Y, et al.
Publicado: (2006)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

0329. Beneficial effects of azithromycin combined with ceftazidime without activity against P. aeruginosa in a murine sepsis model of peritonitis by Pseudomonas aeruginosa
por: Pachón-Ibañez, ME, et al.
Publicado: (2014)

An effective technique for preventing the subcutaneous migration of the abdominal lumboperitoneal shunts catheters
por: Kawahara, Takashi, et al.
Publicado: (2015)

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
por: Foy, Susan P, et al.
Publicado: (2014)

Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
por: Patel, JM, et al.
Publicado: (2011)

Scavengers prevent lung injury but do not improve the survival during sepsis in rats
por: Ohya, M, et al.
Publicado: (2004)

Probiotic pretreatment improves survival and prevents gut mucosal barrier dysfunction in sepsis
por: Calisto, KL, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p9o2q43akplbioemt4f14s3jd4